ArticleInternal medicine (Tokyo, Japan)2024

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.

Masao Hagihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.